The FDA recently approved Kerendia, a new medication that addresses the management of certain complications of type 2 diabetes, including chronic kidney disease and cardiovascular disease.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/09/live-long-and-prosper-with-kerendia-a-new-medication-for-type-2-diabetes/" align="left"]Dr. Edelman takes on the role of an indifferent, judgy doctor and Dr. Pettus plays a clueless patient in these exaggerated scenarios that emphasize the importance of good communication during doctor’s appointments.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/03/good-patient-bad-doctor-bad-patient-good-doctor/" align="left"]Trulicity offers a simple, once-weekly way to control type 2 diabetes and prevent cardiovascular disease (CVD) or help with existing CVD. This GLP-1 RA acts in many ways to help achieve glucose control and a healthier self. Trulicity is simply administered, you don’t ever see a needle and it doesn’t cause weight gain.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/11/concerned-about-needles-try-the-simplicity-of-once-weekly-trulicity/" align="left"]If you have diabetes, should you automatically be on a statin, even if your LDL is in range? Dr. Edelman tackles this often controversial question.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/11/do-you-need-to-be-on-a-statin-if-your-cholesterol-is-in-range/" align="left"]Know Diabetes by Heart and TCOYD held a very important and informative Facebook Live with Know Diabetes By Heart ambassadors Jacqueline Alikhaani and Hyvelle Ferguson, who shared their personal stories dealing with diabetes and cardiovascular disease.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/10/facebook-live-diabetes-cardiovascular-care/" align="left"]




